Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06015438 · ClinicalTrials.gov registry record · NA

Physical Activity in Hidradenitis Suppurativa (HS)

A NA study of Hidradenitis Suppurativa, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06015438: Recruiting NA study of Hidradenitis Suppurativa, sponsored by University of Miami.

NCT06015438 is a NA study of Hidradenitis Suppurativa that is actively recruiting participants, run by University of Miami. The registered enrollment target is 50 participants, below the 597-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06015438, a NA study of Hidradenitis Suppurativa, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to characterize the challenges to physical activity and exercise for HS patients and design an exercise program (EP) with evidence-based techniques and examine its outcome.

Primary Outcome

Determines how many times a person can rise from a chair and sit down again in 30 seconds while keeping their arms crossed over their chest. The test will assess lower body strength and endurance and will be reported using a composite score of the number of times completed.

Conditions Studied

Interventions

  • BEHAVIORAL Home Exercise Program
  • BEHAVIORAL Short Exercise Program

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-06-07
Est. Completion 2026-05-01
Phase NA
University of Miami

721 total trials

What NCT06015438 shows while recruiting

NCT06015438 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 597-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Hidradenitis Suppurativa appearing as the primary indexed condition, and to 2 interventions - of which Home Exercise Program is the first listed.

NCT06015438 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06015438 about?

NCT06015438 is a clinical study titled "Physical Activity in Hidradenitis Suppurativa (HS)". The purpose of the study is to characterize the challenges to physical activity and exercise for HS patients and design an exercise program (EP) with evidence-based techniques and examine its outcome.

What is the current status of trial NCT06015438?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-06-07. Estimated completion is 2026-05-01.

What conditions does trial NCT06015438 study?

This clinical trial studies the following conditions: Hidradenitis Suppurativa.

What interventions are being tested in trial NCT06015438?

The interventions under investigation include: Home Exercise Program (BEHAVIORAL), Short Exercise Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06015438?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06015438 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hidradenitis Suppurativa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06015438's enrollment target sits among peer trials

50 33rd of 52 higher than 19 of 52 other Hidradenitis Suppurativa trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hidradenitis Suppurativa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06015438, the US trial registry maintained by the National Library of Medicine. NCT06015438 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.